guest ::
| Home > Publications database > Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort. > print |
| Home > Publications database > Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort. > print |
| 001 | 153590 | ||
| 005 | 20240229123044.0 | ||
| 024 | 7 | _ | |a 10.1002/ijc.32901 |2 doi |
| 024 | 7 | _ | |a pmid:32011733 |2 pmid |
| 024 | 7 | _ | |a 0020-7136 |2 ISSN |
| 024 | 7 | _ | |a 1097-0215 |2 ISSN |
| 024 | 7 | _ | |a altmetric:75032975 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2020-00334 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Turzanski-Fortner, Renée |0 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort. |
| 260 | _ | _ | |a Bognor Regis |c 2020 |b Wiley-Liss |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1601276043_20420 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2020 Sep 1;147(5):1325-1333#EA:C020#LA:C020# |
| 520 | _ | _ | |a Endometrial cancer (EC) incidence rates vary ~10-fold worldwide, in part due to variation in EC risk factor profiles. Using an EC risk model previously developed in the European EPIC cohort, we evaluated the prevention potential of modified EC risk factor patterns and whether differences in EC incidence between a European population and low-risk countries can be explained by differences in these patterns. Predicted EC incidence rates were estimated over 10 years of follow-up for the cohort before and after modifying risk factor profiles. Risk factors considered were: body mass index (BMI, kg/m2 ), use of postmenopausal hormone therapy (HT) and oral contraceptives (OC) (potentially modifiable); and, parity, ages at first birth, menarche and menopause (environmentally conditioned, but not readily modifiable). Modeled alterations in BMI (to all ≤23 kg/m2 ) and HT use (to all non-HT users) profiles resulted in a 30% reduction in predicted EC incidence rates; individually, longer duration of OC use (to all ≥10 years) resulted in a 42.5% reduction. Modeled changes in not readily modifiable exposures (i.e., those not contributing to prevention potential) resulted in ≤24.6% reduction in predicted EC incidence. Women in the lowest decile of a risk score based on the evaluated exposures had risk similar to a low risk countries; however, this was driven by relatively long use of OCs (median = 23 years). Our findings support avoidance of overweight BMI and of HT use as prevention strategies for EC in a European population; OC use must be considered in the context of benefits and risks. This article is protected by copyright. All rights reserved. |
| 536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Hüsing, Anika |0 P:(DE-He78)6519c85d61a3def7974665471b8a4f74 |b 1 |u dkfz |
| 700 | 1 | _ | |a Dossus, Laure |b 2 |
| 700 | 1 | _ | |a Tjønneland, Anne |b 3 |
| 700 | 1 | _ | |a Overvad, Kim |b 4 |
| 700 | 1 | _ | |a Dahm, Christina C |b 5 |
| 700 | 1 | _ | |a Arveux, Patrick |b 6 |
| 700 | 1 | _ | |a Fournier, Agnès |b 7 |
| 700 | 1 | _ | |a Kvaskoff, Marina |0 0000-0002-4557-3772 |b 8 |
| 700 | 1 | _ | |a Schulze, Matthias B |b 9 |
| 700 | 1 | _ | |a Bergmann, Manuela |b 10 |
| 700 | 1 | _ | |a Trichopoulou, Antonia |b 11 |
| 700 | 1 | _ | |a Karakatsani, Anna |b 12 |
| 700 | 1 | _ | |a La Vecchia, Carlo |0 0000-0003-1441-897X |b 13 |
| 700 | 1 | _ | |a Masala, Giovanna |b 14 |
| 700 | 1 | _ | |a Pala, Valeria |b 15 |
| 700 | 1 | _ | |a Mattiello, Amalia |b 16 |
| 700 | 1 | _ | |a Tumino, Rosario |b 17 |
| 700 | 1 | _ | |a Ricceri, Fulvio |0 0000-0001-8749-9737 |b 18 |
| 700 | 1 | _ | |a van Gils, Carla H |b 19 |
| 700 | 1 | _ | |a Monninkhof, Evelyn M |b 20 |
| 700 | 1 | _ | |a Bonet, Catalina |b 21 |
| 700 | 1 | _ | |a Quirós, J Ramón |b 22 |
| 700 | 1 | _ | |a Sanchez, Maria-Jose |b 23 |
| 700 | 1 | _ | |a Rodríguez-Palacios, Daniel-Ángel |b 24 |
| 700 | 1 | _ | |a Barricarte, Aurelio |b 25 |
| 700 | 1 | _ | |a Amiano, Pilar |b 26 |
| 700 | 1 | _ | |a Allen, Naomi E |b 27 |
| 700 | 1 | _ | |a Travis, Ruth C |b 28 |
| 700 | 1 | _ | |a Gunter, Marc J |b 29 |
| 700 | 1 | _ | |a Viallon, Vivian |b 30 |
| 700 | 1 | _ | |a Weiderpass, Elisabete |0 0000-0003-2237-0128 |b 31 |
| 700 | 1 | _ | |a Riboli, Elio |b 32 |
| 700 | 1 | _ | |a Kaaks, Rudolf |0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |b 33 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1002/ijc.32901 |g p. ijc.32901 |0 PERI:(DE-600)1474822-8 |n 5 |p 1325-1333 |t International journal of cancer |v 147 |y 2020 |x 1097-0215 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:153590 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)6519c85d61a3def7974665471b8a4f74 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 33 |6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b INT J CANCER : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b INT J CANCER : 2017 |
| 920 | 2 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 920 | 0 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|